The objective of the study is to evaluate the feasibility of formulating efavirenz –βCD– PVP K30/SLS inclusion complexes into tablets and to evaluate the effects of βCD, PVP K30and SLS on the dissolution rate and dissolution efficiency of efavirenz
The objective of the study is to evaluatethe feasibility of formulating efavirenz –βCD– PVP K30/SLS inclusion complexes intotablets and to evaluate the effects of βCD, PVP K30and SLS on the dissolution rate anddissolution efficiency of efavirenz